Robust Induction Of Th1-Like γδ T Cells With Anti-Myeloma Activity By Lenalidomide In Combination With HMB-PP As Well As Zoledronic Acid

被引：0
|
作者：
Harada, Takeshi
Cui, Qu
Nakamura, Shingen
Miki, Hirokazu
Oda, Asuka
Amachi, Ryota
Iwasa, Masami
Udaka, Kengo
Fujii, Shiro
Kagawa, Kumiko
Ozaki, Shuji
Tanaka, Yoshimasa
Matsumoto, Toshio
Abe, Masahiro
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.129.129
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
129
引用
收藏
页数：2
相关论文
共 3 条
  • [1] Lenalidomide In Combination with Zoledronic Acid Restores the Activation and,Anti-Myeloma Effects of γδT Cells Attenuated by the Bone Marrow Microenvironment.
    Cui, Qu
    Abe, Masahiro
    Miki, Hirokazu
    Nakamura, Shingen
    Watanabe, Keiichiro
    Ikegame, Akishige
    Hiasa, Masahiro
    Nakano, Ayako
    Harada, Takeshi
    Fujii, Shiro
    Kagawa, Kumiko
    Takeuchi, Kyoko
    Ozaki, Shuji
    Matsumoto, Toshio
    BLOOD, 2010, 116 (21) : 1246 - 1246
  • [2] Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid
    T Harada
    H Miki
    Q Cui
    A Oda
    R Amachi
    J Teramachi
    A Bat-Erdene
    K Sogabe
    M Iwasa
    S Fujii
    S Nakamura
    K Kagawa
    S Yoshida
    I Endo
    K Aihara
    S Ozaki
    T Matsumoto
    M Abe
    Leukemia, 2017, 31 : 258 - 262
  • [3] Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid
    Harada, T.
    Miki, H.
    Cui, Q.
    Oda, A.
    Amachi, R.
    Teramachi, J.
    Bat-Erdene, A.
    Sogabe, K.
    Iwasa, M.
    Fujii, S.
    Nakamura, S.
    Kagawa, K.
    Yoshida, S.
    Endo, I.
    Aihara, K.
    Ozaki, S.
    Matsumoto, T.
    Abe, M.
    LEUKEMIA, 2017, 31 (01) : 258 - 262
1